General 2020 IMV ServiceTrack Awards
Beckman Coulter’s facility in Lismeehan, County Clare, Ireland produces state-of-the-art in-vitro diagnostic devices while stewarding a historic property that is home to ancient landmarks. Since we last reported on this site in 2015, the site:
Beckman Coulter’s facility in Mishima Japan sits at the base of Mount Fuji. Recognizing its unique place in the local ecosystem, the Mishima team leverages DBS to operate under a stringent environmental management system using our Visual Management and Kaizen tools, this team has:
2019 – Beckman Coulter awarded BARDA funding to develop novel sepsis algorithm.
The contract will enable Beckman Coulter, in collaboration with Dascena, Inc, to develop and commercialize a novel machine-learning-based sepsis detection algorithm. By combining novel laboratory test parameter values with electronic health record information, the objective for this next-generation analytic algorithm will be to accurately predict and detect sepsis earlier, with the goals of reducing sepsis mortality through earlier intervention and reducing the total cost of care.
2019 - SelectScience® Scientist's Choice Award: Best New Clinical Instrument (DxH 520)
2019 - MD Buyline Ratings
Our key hematology initiative has been improving quality and reliability for our customers, and the results speak for themselves in our third-party data scores.
2020 – Frost & Sullivan’s Global New Product Innovation Award: Hematology testing market (DxH 690T)
2020 – Beckman Coulter awarded expanded partnership with BARDA to assess sepsis diagnostic and prediction algorithm with COVID-19 patients.
The partnership was awarded to Beckman Coulter, in collaboration with Dascena, Inc., for additional advanced research and development toward optimization of a machine-learning based sepsis diagnostic and prediction algorithm to include assessing its use with coronavirus (COVID-19) patients.
Information addressed to health professionals. The products presented on this site are for professional use only, and, where applicable, comply with the requirements of the IVD Directive 98/79 / EC. Instructions for use must be consulted before using these products.
U.S. Government Users Restricted Rights - As per GSA ADP Schedule Contract with Beckman Coulter, Inc., the use, duplication or disclosure is restricted as follows: Beckman Coulter hereby authorizes user to copy those documents published on the World Wide Web by Beckman Coulter, for noncommercial use, and only within the user's organization. Except as expressly provided above, nothing contained herein shall be construed as granting any license or right under any Beckman Coulter copyright. Nothing contained herein shall be construed as granting by implication, estoppel or otherwise any license or right under any patent or trademark of Beckman Coulter or any third party.